Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita (original) (raw)

Development of Therapeutic siRNAs for Pachyonychia Congenita

Roger Kaspar

Journal of Investigative Dermatology, 2008

View PDFchevron_right

First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin Disorder

Roger Kaspar

Molecular Therapy, 2010

View PDFchevron_right

Use of Self-Delivery siRNAs to Inhibit Gene Expression in an Organotypic Pachyonychia Congenita Model

Devin Leake

Journal of Investigative Dermatology, 2011

View PDFchevron_right

Nonviral delivery of synthetic siRNAs in vivo

Ibrahim Benter

Journal of Clinical Investigation, 2007

View PDFchevron_right

Single-Nucleotide-Specific siRNA Targeting in a Dominant-Negative Skin Model

Roger Kaspar

Journal of Investigative Dermatology, 2007

View PDFchevron_right

Patents Review in siRNA Delivery for Pulmonary Disorders

Sonia Trehan

Recent Patents on Drug Delivery & Formulation, 2012

View PDFchevron_right

Development of Quantitative Molecular Clinical End Points for siRNA Clinical Trials

Sancy Leachman

Journal of Investigative Dermatology, 2011

View PDFchevron_right

TLR9-Targeted SiRNA Delivery In Vivo

Piotr Swiderski

Methods in Molecular Biology, 2016

View PDFchevron_right

Connective tissue growth factor siRNA modulates mRNA levels for a subset of molecules in normal and TGF-?1?stimulated porcine skin fibroblasts

David A Hart

Wound Repair and Regeneration, 2004

View PDFchevron_right

Chemical modification resolves the asymmetry of siRNA strand degradation in human blood serum

Nils Walter

RNA, 2007

View PDFchevron_right

Buffering Capacity and Size of siRNA Polyplexes Influence Cytokine Levels

Archibald Mixson

Molecular Therapy, 2012

View PDFchevron_right

Selection of highly efficient small interference RNA (SiRNA) targeting mammalian genes

ali lakkani

Journal of Biophysical Chemistry, 2013

View PDFchevron_right

Using siRNA to define functional interactions between melanopsin and multiple G Protein partners

Aarti Jagannath

Cellular and Molecular Life Sciences, 2014

View PDFchevron_right

siRNA-Like Double-Stranded RNAs Are Specifically Protected Against Degradation in Human Cell Extract

Nils Walter

PLOS ONE, 2011

View PDFchevron_right

Sirtinol Treatment Reduces Inflammation in Human Dermal Microvascular Endothelial Cells

Angela Orecchia

PLoS ONE, 2011

View PDFchevron_right

Skin and Hair Disorders

Carlo Dionisi Vici

Inherited Metabolic Diseases, 2010

View PDFchevron_right

Silencing of Reporter Gene Expression in Skin Using siRNAs and Expression of Plasmid DNA Delivered by a Soluble Protrusion Array Device (PAD)

Christopher H Contag

Molecular Therapy, 2010

View PDFchevron_right

Generic and Personalized RNAi-Based Therapeutics for a Dominant-Negative Epidermal Fragility Disorder

Christopher H Contag

Journal of Investigative Dermatology, 2012

View PDFchevron_right

SIRT2 Expression Is Higher in Uveal Melanoma than In Ocular Melanocytes

Pablo Zoroquiain

Ocular Oncology and Pathology, 2015

View PDFchevron_right

Non-Invasive Intravital Imaging of siRNA-Mediated Mutant Keratin Gene Repression in Skin

Emilio David Gonzalez

Molecular Imaging and Biology, 2015

View PDFchevron_right

In Silico Evidence of the Relationship Between miRNAs and siRNAs

rita casadio

The Open Applied Informatics Journal, 2008

View PDFchevron_right

LB985 GSK2967901A, a novel small molecule SIRT1 activator for the topical treatment of psoriasis

Han Dai

Journal of Investigative Dermatology, 2017

View PDFchevron_right

Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine

Richard Congo

Molecular Therapy, 2012

View PDFchevron_right

siRNA-based Nanoparticles for Cancer Therapy: Hurdles and Hopes

Stanley Moffatt

MOJ Proteomics & Bioinformatics, 2016

View PDFchevron_right

Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy

Neelam Balekar

Drug Delivery and Translational Research, 2017

View PDFchevron_right

Highly branched HK peptides are effective carriers of siRNA

Archibald Mixson

The Journal of Gene Medicine, 2005

View PDFchevron_right

Transgenic Models of Skin Diseases

Dennis Roop

Archives of Dermatology, 1993

View PDFchevron_right

siRNAs targeting a chromatin-associated RNA induce its transcriptional silencing in human cells

Estelle Nicolas

bioRxiv (Cold Spring Harbor Laboratory), 2022

View PDFchevron_right

Efficient siRNA delivery using osmotically active and biodegradable poly(ester amine)

Rohidas Arote

Advanced Materials Letters, 2018

View PDFchevron_right

siRNA: A Comprehensive Review of Marketed Products till August 2022

Ms. Rupali Ghosh

Journal of Advances in Medical and Pharmaceutical Sciences

View PDFchevron_right

Sirtuin 2 enhances allergic asthmatic inflammation

JOHN CHRISTMAN

JCI Insight, 2019

View PDFchevron_right

Function and anatomy of plant siRNA pools derived from hairpin transgenes

Kevin Lee

Plant Methods, 2007

View PDFchevron_right